Company Analysis
Sign in

SeaStar Medical Holding Corporation (ICU)

Nasdaq: ICU · Surgical & Medical Instruments & Apparatus · Denver, CO · filing with the SEC since 2020
Full chart Alerts Compare
Grade3.9
◀ Past 3.1● Present 1.9▶ Future 7.3
2 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

The grade of SeaStar Medical Holding Corporation

Nine metrics read from its own filings, by tense
Headline grade
3.9/10
◀ Past3.130% of the headline
● Present1.940% of the headline
▶ Future7.330% of the headline

All three tenses have at least two readings, so the archetype blend applies as printed.

Of the nine metrics, 7 read as filed from the record and 2 are SI estimates, each with its reasoning, its confidence and what would change it on its card.

◀ Past

What did they actually do?

3.1/1030% of the headline grade · 2 of 3 filed, 1 estimated

Surviving crises

as filed
0.2/10

Has it survived what it has been through?

22 warning events since 2020; the latest 2025-08-06.

weight 33% of this tense · 2nd percentile among 121 sector filers · read for itself

From the record

SeaStar Medical Holding Corporation's filings since 2020 show 22 warning events of 4 kinds: a notice about its exchange listing (8-K item 3.01, 11 times, the latest 2025-08-06); a warning not to rely on past financial statements (8-K item 4.02, the latest 2024-03-27); an auditor change (8-K item 4.01, 4 times, the latest 2023-11-29); a late-report notice (Form NT 10-K or NT 10-Q, 6 times, the latest 2024-04-01) (its current reports).

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Track record

as filed
6.4/10

What has it actually done, year after year?

3 filed years; profitable in 0 of 3.

weight 45% of this tense · 64th percentile among 105 sector filers · read for its customers

From the record

SeaStar Medical Holding Corporation's 3 filed years say what it did: it rose in 1 of 1 years; it never fell from a peak; net income was positive in 0 of 3 of those years (its annual reports).

What it rests on

  • the share of years revenue rosetop 15% of its family
  • the share of filed years with a profitbottom 23% of its family
  • the deepest fall from a revenue peak0.0%top 16% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Shareholder treatment

SI estimate
0.8/10

How has it treated the people who own it?

SI estimate 0.8/10, confidence 35 of 100 (one part).

weight 22% of this tense · 8th percentile among 120 sector filers · read for its shareholders

SI estimate Inferred, not read as filed

Why it is an estimate
Read from one part only, the share count over the years, which ranks in the bottom 8% of 120 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income.
What the record cannot read
Fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income.
How it was reasoned
one part: the share count over the years, the one part on file, ranked among 120 in its family.
Confidence
35 of 100
What would change it
A filing that carries the missing parts replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: SeaStar Medical Holding Corporation's shareholder treatment is put at 0.8 of 10 with a confidence of 35 of 100, because read from one part only, the share count over the years, which ranks in the bottom 8% of 120 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income. A filing that carries the missing parts replaces this estimate with the filed reading.

● Present

What are they doing right now?

1.9/1040% of the headline grade · 3 of 3 filed

Financial health

as filed
3.1/10

Is it financially healthy right now?

ROE -117%: lost 117¢ per shareholder dollar. Leverage 26%: owes 26¢ per asset dollar.

weight 45% of this tense · 31st percentile among 120 sector filers · read for itself

From the record

Return on equity: in the fiscal year ended 2025-12-31, SeaStar Medical Holding Corporation lost about 117 cents for every dollar of shareholders' money, and gross profitability: its products earned about 8 cents per dollar of everything the company owns. Leverage: it owed about 26 cents per dollar of assets, and net share issuance: its share count grew 453.8% over the year (the filed statements).

What it rests on

  • what it owes per dollar of assetstop 30% of its family
  • return on equitybottom 25% of its family
  • gross profit against assetsbottom 17% of its family
  • the share count against the year beforebottom 10% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Industry position

as filed
1.1/10

How strong is its position in its industry?

bottom 11% of 109 in its family; net margin -984.6%.

weight 33% of this tense · 11th percentile among 109 sector filers · read for its customers

From the record

SeaStar Medical Holding Corporation's standing among 109 graded names in its industry family: revenue of $1 million in fiscal 2025 ranks in the bottom 12% by size; a net margin of -984.6% ranks in the bottom 10% (its annual reports).

What it rests on

  • revenue against the family$1.2Mbottom 12% of its family
  • net margin-984.6%bottom 10% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Leadership

as filed
0.8/10

What are the people in charge doing?

bottom 8% of 91 in its family for leadership; chief executive since 2022.

weight 22% of this tense · 8th percentile among 91 sector filers · read for its shareholders

From the record

SeaStar Medical Holding Corporation's leadership, from its insiders' filings and its current reports: the chief executive on the record is Schlorff, Eric (Chief Executive Officer, as filed), filing under that title since the record of its people begins (2022-10-28), so the years before are not on the record and this part is not read; the 8 officers and directors filing in the last fifteen months have been on the record a median of 2.2 years (bottom 6%); 11 officer or director changes were reported on Form 8-K since 2023-11-13, against the 8 people in charge now (bottom 9%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

What it rests on

  • officer and director changes on Form 8-K, against the people in charge11 in three years among 8 peoplebottom 9% of its family
  • the median years the people in charge have filed2.2 yearsbottom 6% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

▶ Future

What are they set up to do next?

7.3/1030% of the headline grade · 2 of 3 filed, 1 estimated

Room to expand

as filed
6.6/10

How much room does it have to grow?

top 34% of 104 in its family for room to expand.

weight 45% of this tense · 66th percentile among 104 sector filers · read for itself

From the record

SeaStar Medical Holding Corporation's room to grow, from the newest filed statements (fiscal 2025): cash from operations less capital spending is -1102% of revenue (bottom 5%); a gross margin of 95.7% (top 2%); research spending of 609.2% of revenue (top 5%) (its annual report).

What it rests on

  • cash from operations less capital spending against revenue-1102.0%bottom 5% of its family
  • gross margin95.7%top 2% of its family
  • research spending against revenue609.2%top 5% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Growth drivers

as filed
9.6/10

What could actually drive growth from here?

top 4% of 105 in its family for growth drivers.

weight 33% of this tense · 96th percentile among 105 sector filers · read for its customers

From the record

SeaStar Medical Holding Corporation's growth drivers, from the filed years to fiscal 2025: the newest year grew 815.5% (top 1%); research spending grew 44.3% a year (top 6%) (its annual reports). SeaStar Medical Holding Corporation tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.

What it rests on

  • the newest year's revenue growth815.5%top 1% of its family
  • three-year growth of research spending44.3%top 6% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Expectations vs reality

SI estimate
5.1/10

Did its newest year beat what its own record pointed to?

SI estimate 5.1/10, confidence 20 of 100 (family median).

weight 22% of this tense · 50th percentile among 88 sector filers · read for its shareholders

SI estimate Inferred, not read as filed

Why it is an estimate
The record does not carry four filed years of revenue and two of the three parts: revenue against the prior pace, earnings against the prior average, the margin change, so the desk assumes the typical reading of its industry family, the median of 88 members with one.
What the record cannot read
The record does not carry four filed years of revenue and two of the three parts: revenue against the prior pace, earnings against the prior average, the margin change.
How it was reasoned
family median, 88 readings behind it.
Confidence
20 of 100
What would change it
Its next annual report on file with the inputs replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: SeaStar Medical Holding Corporation's expectations vs reality is put at 5.1 of 10 with a confidence of 20 of 100, because the record does not carry four filed years of revenue and two of the three parts: revenue against the prior pace, earnings against the prior average, the margin change, so the desk assumes the typical reading of its industry family, the median of 88 members with one. Its next annual report on file with the inputs replaces this estimate with the filed reading.

The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made

SI Assistanton ICU · research, not advice